Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2008-03-11
2008-03-11
Tran, S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S451000, C424S452000, C424S465000, C424S489000
Reexamination Certificate
active
07341742
ABSTRACT:
A process and pharmaceutical composition containing simethicone and magnesium carbonate allows a higher production rate of simethicone containing tablets and a more consistent end product tablet. The magnesium carbonate prevents sticking of simethicone to tablet compressing apparatuses, and may also prevent sticking of other excipients to tablet compressing apparatuses.
REFERENCES:
patent: 2951011 (1960-08-01), Feinstone
patent: 3767794 (1973-10-01), McVean et al.
patent: 4127650 (1978-11-01), Buehler
patent: 4230693 (1980-10-01), Izzo et al.
patent: 4301149 (1981-11-01), Crowley
patent: 4327076 (1982-04-01), Puglia et al.
patent: 4396604 (1983-08-01), Mitra
patent: 4486412 (1984-12-01), Shah et al.
patent: 5073384 (1991-12-01), Valentine et al.
patent: 5219574 (1993-06-01), Wehling et al.
patent: 5401513 (1995-03-01), Wehling et al.
patent: 5599577 (1997-02-01), Stevens et al.
patent: 6103260 (2000-08-01), Luber et al.
patent: 2003/0091624 (2003-05-01), Szymczak et al.
patent: 1 042 796 (1978-11-01), None
patent: 1042796 (1978-11-01), None
patent: 1 139 221 (1983-01-01), None
patent: 1139221 (1983-01-01), None
Danielson Douglas W.
Schuehle Steven S.
Shah Shirish A.
L. Perrigo Company
Price Heneveld Cooper DeWitt & Litton LLP
Tran S.
LandOfFree
Simethicone containing tablet composition and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Simethicone containing tablet composition and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Simethicone containing tablet composition and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2806030